This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sanofi. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Farid Abdul-Latif: Innovator in Pharmaceutical Modulation
Introduction
Farid Abdul-Latif is a notable inventor based in Oro Valley, AZ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate APJ receptors. His work is essential for addressing health issues related to increased blood pressure.
Latest Patents
Farid holds 1 patent for his invention titled "Benzoimidazole-carboxylic acid amide derivatives as APJ receptor modulators." This invention relates to benzoimidazole-carboxylic acid amide compounds, which are useful in treating diseases associated with elevated blood pressure. The compounds are designed to serve as active ingredients in pharmaceuticals, enhancing their therapeutic efficacy.
Career Highlights
Farid Abdul-Latif is associated with Sanofi, a leading global healthcare company. His role involves research and development of innovative pharmaceutical solutions. His expertise in receptor modulation has positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
Farid has collaborated with notable colleagues, including Stephanie Hachtel and Paulus Wohlfart. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Farid Abdul-Latif's contributions to pharmaceutical innovation highlight the importance of research in developing effective treatments for health conditions. His work continues to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile